Skip to main content

Advertisement

Log in

Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies

  • Original article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Quantitative methods for calculation of regional cerebral blood flow with technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) have been proposed. These methods are very labour intensive and therefore are not useful in routine clinical practice. We describe a simple alternative method, using calibrated point sources as a scaling factor, whereby the tomographic slices are displayed as regional 99mTc-HMPAO brain uptake per cm3 brain tissue in 10−6 of the injected lipophilic dose. The method was validated on Jaszczak and Hoffman phantoms using a three-detector system with HR parallel and HR fan-beam collimators. Under the optimal conditions described in this paper, the measured to real activity ratio was 1.00 (SD = 0.06). The reproducibility of the cerebellar uptake in a group of ten normal volunteers and five patients was studied. Intra-individually a mean deviation of 12.6% was observed for the total group. For those persons with a heart rate difference of less than 5 units between the two studies, a mean deviation of 7.2% was obtained. Quantitative 99mTc-HMPAO brain uptake images can be useful for longitudinal studies, especially for follow-up, activation and pharmacological studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sharp PF, Smith FW, Gemmell HG, et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986;27:171–177.

    Google Scholar 

  2. Costa DC, Ell PJ, Cullum ID, Jarritt PH. The in vivo distribution of 99TcmHM-PAO in normal man. Nuel Med Commun 1986:7:647–658.

    Google Scholar 

  3. Nowotnik DP, Canning LR, Cumming SA, et al. Development of a Tc-99m-labelled radiopharmaceutical for cerebral blood flow imaging. Nucl Med Commun 1985; 6:499–506.

    Google Scholar 

  4. Matsuda H, Oba H, Seki H, et al. Determination of flow and rate constants in a kinetic model of 99mTc-hexamethyl-propy-lene amine oxime in the human brain. J Cereb Blood Flow Metab 1988;8:61–68.

    Google Scholar 

  5. Nickel O, Nägele-Wöhrle B, Ulrich P, et al. rCBF-quantification with 99mTc-HMPAO-SPECT: theory and first results. Eur J Nucl Med 1989;15:1–8.

    Google Scholar 

  6. Pupi A, De Cristofaro M, Bacciottini L et al. An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography. J Nuel Med 1991;32:1501–1506.

    Google Scholar 

  7. Murase K, Tanada S, Fujita H, et al. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. J Nuel Med 1992:33:135–143.

    Google Scholar 

  8. Matsuda H, Tsuji S, Shuke N, et al. A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1992;19:195–200.

    Google Scholar 

  9. Szabo Z, Monsein LH, Maruki et al. Quantitative imaging of CBF with Tc-99m HMPAO [abstract]. Eur J Nucl Med 1991:18:667.

    Google Scholar 

  10. Nakamura K, Tukatani Y, Kubo A, et al. The behavior of 99Tc-hexamethyl propyleneamineoxime (99mTc-HMPAO) in blood and brain. Eur J Nuel Med 1989;15:100–107.

    Google Scholar 

  11. Hoffman EJ, Cutler PD, Digby WM, Mazziotta JC. 3-D phantom to simulate cerebral blood flow and metabolic images for PET. IEEE Trans Nucl Sci 1990; 37:616–620.

    Google Scholar 

  12. Hung JC, Corlija M, Volkert WA, Holmes RA. Kinetic analysis of technetium-99m d,I-HM-PAO decomposition in aqueous media. J Nuel Med 1988;29:1568–1576.

    Google Scholar 

  13. Galt JR, Grant SF, Alazraki NP. Effect of system resolution on quantitative measurements of the cerebral cortex and cerebellum and Spect brain images [abstract]. J Nucl Med 1991;32:728.

    Google Scholar 

  14. Dobbeleir A, Dierckx R, Vandevivere J. High spatial resolution Spect using a three-head rotating gamma camera and super fine lead fan-beam collimators [abstract]. Eur J Nucl Med 1991;18:600.

    Google Scholar 

  15. Kojima A, Matsumoto M, Takahashi M, et al. Effect of spatial resolution on Spect quantification values. J Nucl Med 1989;30:508–514.

    Google Scholar 

  16. Szabo Z, Seki C, Rhine J, et al. Effect of spatial resolution on absolute quantification with high resolution Spect [abstract]. Eur J Nucl Med 1991;18:604.

    Google Scholar 

  17. Kim HJ, Zeeberg B, Fahey F, et al. Three-dimensional Spect simulations of a complex three-dimensional mathematical brain model and measurements of the three-dimensional physical brain phantom. J Nucl Med 1991; 32:1923–1930.

    Google Scholar 

  18. 18.Syed G, Eagger S, Toone B, et al. Quantification of regional cerebral blood flow (rCBF) using 99TcmHM-PAO and SPECT: choice of the reference region. Nucl Med Commun 1992;13:811–816.

    Google Scholar 

  19. 19.Podreka I, Goldenberg G, Baumgartner C, et al. HMPAO brain uptake in young normal subjects: gender differences and hemispheric asymmetries. J Cereb Blood Flow Metab 1989;9 Suppl 1:202.

    Google Scholar 

  20. Lassen N, Andersen A, Friberg L, Paulson O, The retention of 99Tcm-d,I-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8 (Suppl):S13-S22.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: A. Dobbeleir

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dobbeleir, A., Dierckx, R. Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies. Eur J Nucl Med 20, 684–689 (1993). https://doi.org/10.1007/BF00181759

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00181759

Key words

Navigation